The Cost–Effectiveness Of Regorafenib In The Treatment Of Patients With Metastatic Colorectal Cancer (Mcrc) Who Have Progressed After Standard Therapies In Turkey
Abstract
Authors
C Deger F Telli M Gunaldi S Keskin S Saglam O Ozdemir C Sar E Parali E Erdal F Sumer O Ozel S Asan